Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia

Luisa Benerini Gatta, Angiola Berenzi, Piera Balzarini, Enrico Dessy, Francesca Angiero, Giulio Alessandri, Angela Gambino, Piergiovanni Grigolato, Anna Benetti

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The expressions of p16, Ki-67, and L1 proteins and human papillomavirus DNA were investigated using polymerase chain reaction (HPV/PCR) and catalyzed signal-amplified colorimetric DNA in situ hybridization (CSAC/ISH) as potential molecular markers for the diagnosis and transforming potential of low cervical intraepithelial neoplasia (CIN1). Ki-67 and p16 protein expression increased linearly from control cases to more dysplastic cases (CIN1, CIN2, and CIN3), peaking in squamous cell carcinoma cases (P-p16 +, L1 +p16 -, L1 -p16 -, and L1 +p16 +, and the immunohistochemical results were combined with HPV/PCR, L1/PCR, and high-risk E6/E7 genome and CSAC/ISH data. Malignant transformation correlated with L1 -p16 + patients (100% of CIN2, CIN3, and squamous cell carcinoma cases) and was evident in approximately 23% of CIN1 cases. In addition, the presence of HPV/DNA + was evident in 52% of CIN1 cases, and within the L1 -p16 + group. In 4 of 7 cases, the high-risk E6/E7 HPV genome was present and in 1 case it was integrated into the host DNA, as confirmed using CSAC/ISH. In patients with CIN1, investigating the presence of HPV/DNA using PCR and the presence of the high-risk E6/E7 genome is necessary to distinguish high-risk oncogenic patient groups from low-risk groups. This study highlights the importance of combining immunohistochemical analysis with HPV/PCR and CSAC/ISH to identify patients with CIN1 with a risk of neoplastic progression.

Original languageEnglish
Pages (from-to)597-604
Number of pages8
JournalInternational Journal of Gynecological Pathology
Volume30
Issue number6
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Cervical Intraepithelial Neoplasia
DNA
Polymerase Chain Reaction
In Situ Hybridization
Proteins
Genome
Squamous Cell Carcinoma

Keywords

  • Cervix
  • CIN1
  • HPV DNA
  • L1
  • p16

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynaecology

Cite this

Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia. / Gatta, Luisa Benerini; Berenzi, Angiola; Balzarini, Piera; Dessy, Enrico; Angiero, Francesca; Alessandri, Giulio; Gambino, Angela; Grigolato, Piergiovanni; Benetti, Anna.

In: International Journal of Gynecological Pathology, Vol. 30, No. 6, 11.2011, p. 597-604.

Research output: Contribution to journalArticle

Gatta, LB, Berenzi, A, Balzarini, P, Dessy, E, Angiero, F, Alessandri, G, Gambino, A, Grigolato, P & Benetti, A 2011, 'Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia', International Journal of Gynecological Pathology, vol. 30, no. 6, pp. 597-604. https://doi.org/10.1097/PGP.0b013e31821ac4fd
Gatta, Luisa Benerini ; Berenzi, Angiola ; Balzarini, Piera ; Dessy, Enrico ; Angiero, Francesca ; Alessandri, Giulio ; Gambino, Angela ; Grigolato, Piergiovanni ; Benetti, Anna. / Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia. In: International Journal of Gynecological Pathology. 2011 ; Vol. 30, No. 6. pp. 597-604.
@article{f7f386904737416e989d0a87bd0de08f,
title = "Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia",
abstract = "The expressions of p16, Ki-67, and L1 proteins and human papillomavirus DNA were investigated using polymerase chain reaction (HPV/PCR) and catalyzed signal-amplified colorimetric DNA in situ hybridization (CSAC/ISH) as potential molecular markers for the diagnosis and transforming potential of low cervical intraepithelial neoplasia (CIN1). Ki-67 and p16 protein expression increased linearly from control cases to more dysplastic cases (CIN1, CIN2, and CIN3), peaking in squamous cell carcinoma cases (P-p16 +, L1 +p16 -, L1 -p16 -, and L1 +p16 +, and the immunohistochemical results were combined with HPV/PCR, L1/PCR, and high-risk E6/E7 genome and CSAC/ISH data. Malignant transformation correlated with L1 -p16 + patients (100{\%} of CIN2, CIN3, and squamous cell carcinoma cases) and was evident in approximately 23{\%} of CIN1 cases. In addition, the presence of HPV/DNA + was evident in 52{\%} of CIN1 cases, and within the L1 -p16 + group. In 4 of 7 cases, the high-risk E6/E7 HPV genome was present and in 1 case it was integrated into the host DNA, as confirmed using CSAC/ISH. In patients with CIN1, investigating the presence of HPV/DNA using PCR and the presence of the high-risk E6/E7 genome is necessary to distinguish high-risk oncogenic patient groups from low-risk groups. This study highlights the importance of combining immunohistochemical analysis with HPV/PCR and CSAC/ISH to identify patients with CIN1 with a risk of neoplastic progression.",
keywords = "Cervix, CIN1, HPV DNA, L1, p16",
author = "Gatta, {Luisa Benerini} and Angiola Berenzi and Piera Balzarini and Enrico Dessy and Francesca Angiero and Giulio Alessandri and Angela Gambino and Piergiovanni Grigolato and Anna Benetti",
year = "2011",
month = "11",
doi = "10.1097/PGP.0b013e31821ac4fd",
language = "English",
volume = "30",
pages = "597--604",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia

AU - Gatta, Luisa Benerini

AU - Berenzi, Angiola

AU - Balzarini, Piera

AU - Dessy, Enrico

AU - Angiero, Francesca

AU - Alessandri, Giulio

AU - Gambino, Angela

AU - Grigolato, Piergiovanni

AU - Benetti, Anna

PY - 2011/11

Y1 - 2011/11

N2 - The expressions of p16, Ki-67, and L1 proteins and human papillomavirus DNA were investigated using polymerase chain reaction (HPV/PCR) and catalyzed signal-amplified colorimetric DNA in situ hybridization (CSAC/ISH) as potential molecular markers for the diagnosis and transforming potential of low cervical intraepithelial neoplasia (CIN1). Ki-67 and p16 protein expression increased linearly from control cases to more dysplastic cases (CIN1, CIN2, and CIN3), peaking in squamous cell carcinoma cases (P-p16 +, L1 +p16 -, L1 -p16 -, and L1 +p16 +, and the immunohistochemical results were combined with HPV/PCR, L1/PCR, and high-risk E6/E7 genome and CSAC/ISH data. Malignant transformation correlated with L1 -p16 + patients (100% of CIN2, CIN3, and squamous cell carcinoma cases) and was evident in approximately 23% of CIN1 cases. In addition, the presence of HPV/DNA + was evident in 52% of CIN1 cases, and within the L1 -p16 + group. In 4 of 7 cases, the high-risk E6/E7 HPV genome was present and in 1 case it was integrated into the host DNA, as confirmed using CSAC/ISH. In patients with CIN1, investigating the presence of HPV/DNA using PCR and the presence of the high-risk E6/E7 genome is necessary to distinguish high-risk oncogenic patient groups from low-risk groups. This study highlights the importance of combining immunohistochemical analysis with HPV/PCR and CSAC/ISH to identify patients with CIN1 with a risk of neoplastic progression.

AB - The expressions of p16, Ki-67, and L1 proteins and human papillomavirus DNA were investigated using polymerase chain reaction (HPV/PCR) and catalyzed signal-amplified colorimetric DNA in situ hybridization (CSAC/ISH) as potential molecular markers for the diagnosis and transforming potential of low cervical intraepithelial neoplasia (CIN1). Ki-67 and p16 protein expression increased linearly from control cases to more dysplastic cases (CIN1, CIN2, and CIN3), peaking in squamous cell carcinoma cases (P-p16 +, L1 +p16 -, L1 -p16 -, and L1 +p16 +, and the immunohistochemical results were combined with HPV/PCR, L1/PCR, and high-risk E6/E7 genome and CSAC/ISH data. Malignant transformation correlated with L1 -p16 + patients (100% of CIN2, CIN3, and squamous cell carcinoma cases) and was evident in approximately 23% of CIN1 cases. In addition, the presence of HPV/DNA + was evident in 52% of CIN1 cases, and within the L1 -p16 + group. In 4 of 7 cases, the high-risk E6/E7 HPV genome was present and in 1 case it was integrated into the host DNA, as confirmed using CSAC/ISH. In patients with CIN1, investigating the presence of HPV/DNA using PCR and the presence of the high-risk E6/E7 genome is necessary to distinguish high-risk oncogenic patient groups from low-risk groups. This study highlights the importance of combining immunohistochemical analysis with HPV/PCR and CSAC/ISH to identify patients with CIN1 with a risk of neoplastic progression.

KW - Cervix

KW - CIN1

KW - HPV DNA

KW - L1

KW - p16

UR - http://www.scopus.com/inward/record.url?scp=80053975516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053975516&partnerID=8YFLogxK

U2 - 10.1097/PGP.0b013e31821ac4fd

DO - 10.1097/PGP.0b013e31821ac4fd

M3 - Article

C2 - 21979598

AN - SCOPUS:80053975516

VL - 30

SP - 597

EP - 604

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 6

ER -